Sorry but for the first time ever the FDA is going to approve a drug that failed it's FDA trial. Didn't even get to the end. Nope, failed on the first look in. Not even close. Futility. Nice word to be associated with.
I agree. Probably at least 1/100 RS leaving 4M or 5M outstanding shares. That will solve everything. It is important to limit the liquidity in the stock. Do I sound crazy? Just trying to fit in
Market Data 
Markets 
AI
